CTO · CTO Realty Growth, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-01 | Haga Christopher W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 2nd quarter 2026 board retainer fee of $12,500 and committee retainer fees of $8,437.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $20.83450. |
Common Stock
|
1,004 |
| 2026-07-01 | Drew Christopher J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 2nd quarter 2026 board retainer fee of $12,500 and committee retainer fees of $3,750 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $20.83450. |
Common Stock
|
779 |
| 2026-07-01 | Gable Robert Blakeslee |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 2nd quarter 2026 board retainer fee of $12,500 and committee retainer fees of $6,562.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $20.83450. |
Common Stock
|
914 |
| 2026-07-01 | FRANKLIN LAURA M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of her 2nd quarter 2026 board retainer fee of $12,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $20.83450. This amount includes 256.255 shares acquired through the Issuer's dividend reinvestment plan since April 2, 2026 (the date of the Reporting Person's prior Form 4 filing). |
Common Stock
|
599 |
| 2026-04-01 | Haga Christopher W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 1st quarter 2026 board retainer fee of $12,500 and committee retainer fees of $8,437.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.88350. |
Common Stock
|
1,108 |
| 2026-04-01 | FRANKLIN LAURA M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of her 1st quarter 2026 board retainer fee of $12,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.88350. This amount includes 294.765 shares acquired through the Issuer's dividend reinvestment plan since February 13, 2026 (the date of the Reporting Person's prior Form 4 filing). |
Common Stock
|
661 |
| 2026-04-01 | Drew Christopher J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 1st quarter 2026 board retainer fee of $12,500 and committee retainer fees of $3,750 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.88350. |
Common Stock
|
860 |
| 2026-04-01 | Gable Robert Blakeslee |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 1st quarter 2026 board retainer fee of $12,500 and committee retainer fees of $6,562.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.88350. |
Common Stock
|
1,009 |
| 2026-02-11 | Brokaw George R |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person as his $62,500 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 5, 2026, or $18.05000. |
Common Stock
|
3,462 |
| 2026-02-11 | Mays Philip |
SVP, CFO & Treasurer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2026, provided that the reporting person is an employee of the Issuer on those dates. This amount consists of the 14,965 newly issued restricted shares reported above, as well as 8,561 additional shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
14,965 |
| 2026-02-11 | Greathouse Steven Robert |
SVP & Chief Investment Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2026, provided that the reporting person is an employee of the Issuer on those dates. This amount consists of the 17,487 newly issued restricted shares reported above, as well as 15,571 additional shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
17,487 |
| 2026-02-11 | Haga Christopher W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person as his $62,500 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 5, 2026, or $18.05000. |
Common Stock
|
3,462 |
| 2026-02-11 | Smith Daniel Earl |
SVP, GEN COUNSEL & CORP SECRET |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2026, provided that the reporting person is an employee of the Issuer on those dates. This amount includes the 11,266 newly issued restricted shares reported above, as well as 10,544 additional shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
11,266 |
| 2026-02-11 | Gable Robert Blakeslee |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person as his $62,500 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 5, 2026, or $18.05000. |
Common Stock
|
3,462 |
| 2026-02-11 | Vorakoun Lisa |
VP & Chief Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2026, provided that the reporting person is an employee of the Issuer on those dates. This amount consists of the 10,089 newly issued restricted shares reported above, as well as 8,484 additional shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
10,089 |
| 2026-02-11 | Albright John P |
Director, PRESIDENT AND CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted shares one-third of which vest on each of the first, second and third anniversaries of January 28, 2026, provided that the reporting person is an employee of the Issuer on those dates. This amount includes the 37,114 newly issued restricted shares reported above, as well as 32,607 additional shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
37,114 |
| 2026-02-11 | Drew Christopher J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person as his $62,500 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 5, 2026, or $18.05000. |
Common Stock
|
3,462 |
| 2026-02-11 | FRANKLIN LAURA M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person as her $62,500 "Annual Award" pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of February 5, 2026, or $18.05000. |
Common Stock
|
3,462 |
| 2026-01-28 | Smith Daniel Earl |
SVP, GEN COUNSEL & CORP SECRET |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 28, 2025, a total of 11,559 shares of restricted common stock of the Issuer previously awarded to the Reporting Person became vested and unrestricted. A portion of the vesting shares was withheld by the Issuer in order to satisfy the Reporting Person's tax liability. This amount includes 10,544 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
4,548 |
| 2026-01-28 | Mays Philip |
SVP, CFO & Treasurer |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 28, 2026, a total of 4,280 shares of restricted common stock of the Issuer previously awarded to the Reporting Person became vested and unrestricted. A portion of the vesting shares was withheld by the Issuer in order to satisfy the Reporting Person's tax liability. This amount includes 8,561 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
1,269 |
| 2026-01-28 | Vorakoun Lisa |
VP & Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 28, 2026, a total of 7,314 shares of restricted common stock of the Issuer previously awarded to the Reporting Person became vested and unrestricted. A portion of the vesting shares was withheld by the Issuer in order to satisfy the Reporting Person's tax liability. This amount includes 8,484 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
1,876 |
| 2026-01-28 | Albright John P |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 28, 2026, a total of 29,803 shares of restricted common stock of the Issuer previously awarded to the Reporting Person became vested and unrestricted. A portion of the vesting shares was withheld by the Issuer in order to satisfy the Reporting Person's tax liability. This amount includes 32,607 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
11,727 |
| 2026-01-28 | Greathouse Steven Robert |
SVP & Chief Investment Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 28, 2026, a total of 14,430 shares of restricted common stock of the Issuer previously awarded to the Reporting Person became vested and unrestricted. A portion of the vesting shares was withheld by the Issuer in order to satisfy the Reporting Person's tax liability. This amount includes 15,571 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
3,513 |
| 2026-01-12 | Vorakoun Lisa |
VP & Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 12, 2026, the Reporting Person instructed the Issuer to withhold 1,635 of the Issued Shares to satisfy the Reporting Person's payroll tax liability. This amount includes 15,798 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
1,635 |
| 2026-01-12 | Greathouse Steven Robert |
SVP & Chief Investment Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On January 12, 2026, the Issuer issued 22,662 shares of its common stock (the "Issued Shares") to the Reporting Person. The Issued Shares were issued pursuant to a Performance Shares Award Agreement between the Issuer and the Reporting Person dated February 17, 2023, the form of which has been filed as an exhibit to the Issuer's annual report on Form 10-K for the year ended December 31, 2022. This amount includes 30,001 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
22,662 |
| 2026-01-12 | Albright John P |
Director, PRESIDENT AND CEO |
Award↑
Filing footnotes — Common Stock (Direct)
On January 12, 2026, the Issuer issued 59,163 shares of its common stock (the "Issued Shares") to the Reporting Person. The Issued Shares were issued pursuant to a Performance Shares Award Agreement between the Issuer and the Reporting Person dated February 17, 2023, the form of which has been filed as an exhibit to the Issuer's annual report on Form 10-K for the year ended December 31, 2022. This amount includes 62,410 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
59,163 |
| 2026-01-12 | Albright John P |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 12, 2026, the Reporting Person instructed the Issuer to withhold 23,702 of the Issued Shares to satisfy the Reporting Person's payroll tax liability. This amount includes 62,410 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
23,702 |
| 2026-01-12 | Smith Daniel Earl |
SVP, GEN COUNSEL & CORP SECRET |
Award↑
Filing footnotes — Common Stock (Direct)
On January 12, 2026, the Issuer issued 16,997 shares of its common stock (the "Issued Shares") to the Reporting Person. The Issued Shares were issued pursuant to a Performance Shares Award Agreement between the Issuer and the Reporting Person dated February 17, 2023, the form of which has been filed as an exhibit to the Issuer's annual report on Form 10-K for the year ended December 31, 2022. This amount includes 22,103 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
16,997 |
| 2026-01-12 | Vorakoun Lisa |
VP & Chief Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On January 12, 2026, the Issuer issued 5,516 shares of its common stock (the "Issued Shares") to the Reporting Person. The Issued Shares were issued pursuant to a Performance Shares Award Agreement between the Issuer and the Reporting Person dated February 17, 2023, the form of which has been filed as an exhibit to the Issuer's annual report on Form 10-K for the year ended December 31, 2022. This amount includes 15,798 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
5,516 |
| 2026-01-12 | Smith Daniel Earl |
SVP, GEN COUNSEL & CORP SECRET |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 12, 2026, the Reporting Person instructed the Issuer to withhold 7,174 of the Issued Shares to satisfy the Reporting Person's payroll tax liability. This amount includes 22,103 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
7,174 |
| 2026-01-12 | Greathouse Steven Robert |
SVP & Chief Investment Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
On January 12, 2026, the Reporting Person instructed the Issuer to withhold 5,981 of the Issued Shares to satisfy the Reporting Person's payroll tax liability. This amount includes 30,001 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
5,981 |
| 2026-01-02 | Gable Robert Blakeslee |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 4th quarter 2025 board retainer fee of $12,500 and committee retainer fees of $6,562.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.01750. |
Common Stock
|
1,057 |
| 2026-01-02 | FRANKLIN LAURA M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of her 4th quarter 2025 board retainer fee of $12,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.01750. |
Common Stock
|
693 |
| 2026-01-02 | Haga Christopher W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 4th quarter 2025 board retainer fee of $12,500 and committee retainer fees of $8,437.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.01750. |
Common Stock
|
1,162 |
| 2026-01-02 | Drew Christopher J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 4th quarter 2025 board retainer fee of $12,500 and committee retainer fees of $3,750 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.01750. |
Common Stock
|
901 |
| 2025-12-29 | Smith Daniel Earl |
SVP, GEN COUNSEL & CORP SECRET |
Gift↓
Filing footnotes — Common Stock (Direct)
This amount includes 22,103 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
2,000 |
| 2025-12-26 | Smith Daniel Earl |
SVP, GEN COUNSEL & CORP SECRET |
Gift↓
Filing footnotes — Common Stock (Direct)
This amount includes 22,103 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
195 |
| 2025-10-01 | Haga Christopher W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 3rd quarter 2025 board retainer fee of $12,500 and committee retainer fees of $8,437.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $16.54450. |
Common Stock
|
1,265 |
| 2025-10-01 | Gable Robert Blakeslee |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 3rd quarter 2025 board retainer fee of $12,500 and committee retainer fees of $6,562.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $16.54450. |
Common Stock
|
1,152 |
| 2025-10-01 | Drew Christopher J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 3rd quarter 2025 board retainer fee of $12,500 and committee retainer fees of $3,750 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $16.54450. |
Common Stock
|
982 |
| 2025-10-01 | FRANKLIN LAURA M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of her 3rd quarter 2025 board retainer fee of $12,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $16.54450. This amount includes 334.274 shares acquired through the Issuer's dividend reinvestment plan since July 3, 2025 (the date of the Reporting Person's prior Form 4 filing). |
Common Stock
|
755 |
| 2025-09-16 | Albright John P |
Director, PRESIDENT AND CEO |
Buy↑
Filing footnotes — Common Stock (Direct)
This amount includes 62,410 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
2,000 |
| 2025-09-12 | Vorakoun Lisa |
VP & Chief Accounting Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
This amount includes 15,798 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
750 |
| 2025-09-12 | Greathouse Steven Robert |
SVP & Chief Investment Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
This amount includes 30,001 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
600 |
| 2025-09-11 | Smith Daniel Earl |
SVP, GEN COUNSEL & CORP SECRET |
Buy↑
Filing footnotes — Common Stock (Direct)
This amount includes 22,103 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
1,000 |
| 2025-09-11 | Mays Philip |
SVP, CFO & Treasurer |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $16.59 to $16.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. This amount includes 12,841 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
1,000 |
| 2025-09-11 | Albright John P |
Director, PRESIDENT AND CEO |
Buy↑
Filing footnotes — Common Stock (Direct)
The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $16.51 to $16.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. This amount includes 62,410 shares of restricted common stock which vest over time, which were previously reported. |
Common Stock
|
4,200 |
| 2025-07-01 | Drew Christopher J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 2nd quarter 2025 board retainer fee of $12,500 and committee retainer fees of $3,750.00 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.126500. |
Common Stock
|
896 |
| 2025-07-01 | Haga Christopher W |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of his 2nd quarter 2025 board retainer fee of $12,500 and committee retainer fees of $8,437.50 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.126500. |
Common Stock
|
1,155 |
| 2025-07-01 | FRANKLIN LAURA M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
These shares were issued to the Reporting Person in lieu of her 2nd quarter 2025 board retainer fee of $12,500 pursuant to the Issuer's Non-Employee Director Compensation Policy (the "Policy") adopted by the Issuer's board of directors on February 27, 2019 (last amended February 14, 2024). Pursuant to the Policy, the share price utilized to calculate the number of shares issued was the 20-day trailing average closing price as of the last business day of the calendar quarter, or $18.126500. This amount includes 297.493 shares acquired through the Issuer's dividend reinvestment plan since April 1, 2025 (the date of the Reporting Person's prior Form 4 filing). |
Common Stock
|
689 |